Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00326859Phase 4Terminated
A Phase 4 trial of remifentanil in procedural pain, sponsored by Montreal Burn Centre. Started Aug 2005; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00326859.